Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan.
Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan.
Autoimmun Rev. 2019 Sep;18(9):102354. doi: 10.1016/j.autrev.2019.102354. Epub 2019 Jul 16.
Immunoglobulin G4 (IgG4)-related disease is a systemic chronic fibroinflammatory disease that can affect almost every organ of the body. IgG4-related periaortitis/periarteritis is a newly recognized subset of IgG4-related disease, and its characteristics and prognosis remain unclear. We investigated the clinical characteristics and prognosis of IgG4-related periaortitis/periarteritis.
We performed a systematic literature review of IgG4-related periaortitis/periarteritis. Additionally, we have summarized the characteristics and prognosis of IgG4-related coronary arteritis.
We investigated 248 patients with IgG4-related periaortitis/periarteritis. All studies reported the condition in elderly patients, and male predominance was observed. The infra-renal abdominal aorta and iliac arteries were the most commonly affected sites. Most reports showed the serum C-reactive protein elevation in this disease entity, in contrast to non-vascular IgG4-related disease. Based on radiological findings observed in 27 patients with IgG4-related coronary arteritis, vasculitic lesions were classified into 3 types: stenotic (67% of patients), aneurysmal (42%), and diffuse wall thickening type (92%). Serum IgG4 level, but not C-reactive protein level, was associated with the number of affected organs in IgG4-related coronary arteritis. Corticosteroid treatment with or without cardiac surgery or percutaneous coronary intervention was effective in most patients with IgG4-related coronary arteritis; however, 33% of patients showed an unfavorable clinical course including disease progression, relapse, or death. Pre-treatment stenosis and/or aneurysms were associated with progression of stenosis or aneurysm after corticosteroid treatment.
Most clinical characteristics were similar between the IgG4-related periaortitis/periarteritis and the non-vascular IgG4-related disease groups; however, serum C-reactive protein level elevation was observed only in the former. Although corticosteroid treatment was effective, this disease can be life-threatening secondary to myocardial infarction, aortic dissection, and aneurysmal rupture. Pre-treatment evaluation of stenosis or aneurysms is important for predicting progression of stenosis or aneurysm after corticosteroid treatment.
免疫球蛋白 G4(IgG4)相关疾病是一种全身性慢性纤维炎症性疾病,几乎可影响身体的每个器官。IgG4 相关大动脉炎/动脉周炎是一种新认识的 IgG4 相关疾病亚类,其特征和预后尚不清楚。我们研究了 IgG4 相关大动脉炎/动脉周炎的临床特征和预后。
我们对 IgG4 相关大动脉炎/动脉周炎进行了系统的文献回顾。此外,我们还总结了 IgG4 相关冠状动脉炎的特征和预后。
我们研究了 248 例 IgG4 相关大动脉炎/动脉周炎患者。所有研究均报告了老年患者发病,且男性居多。下肾腹主动脉和髂动脉是最常受累的部位。与非血管 IgG4 相关疾病相比,大多数报告显示该疾病实体存在血清 C 反应蛋白升高。基于 27 例 IgG4 相关冠状动脉炎患者的影像学发现,血管炎性病变可分为 3 种类型:狭窄型(67%的患者)、动脉瘤型(42%)和弥漫性管壁增厚型(92%)。血清 IgG4 水平,但不是 C 反应蛋白水平,与 IgG4 相关冠状动脉炎受累器官数量相关。大多数 IgG4 相关冠状动脉炎患者对皮质类固醇治疗联合或不联合心脏手术或经皮冠状动脉介入治疗有效;然而,33%的患者出现不良临床病程,包括疾病进展、复发或死亡。皮质类固醇治疗前狭窄和/或动脉瘤与治疗后狭窄或动脉瘤进展相关。
大多数临床特征在 IgG4 相关大动脉炎/动脉周炎与非血管 IgG4 相关疾病组之间相似;然而,仅在前一组中观察到血清 C 反应蛋白水平升高。虽然皮质类固醇治疗有效,但由于心肌梗死、主动脉夹层和动脉瘤破裂,这种疾病可能危及生命。皮质类固醇治疗前对狭窄或动脉瘤的评估对于预测治疗后狭窄或动脉瘤的进展很重要。